Clinical Trials

Clinical trials and studies about imaging technology can be found on this channel.

Nuclidium and University Hospital Basel Receive NETRF Investigator Award to Initiate Phase 1 Trial with Novel Copper-based Radiotheranostic Program TraceNET in Neuroendocrine Tumors

March 23, 2023 — Nuclidium announced that the Neuroendocrine Tumors Research Foundation (NETRF) has selected the company ...

March 24, 2023

Positron Corporation, a molecular imaging device company that offers PET imaging systems and clinical services, is pleased to announce that it has executed a Clinical Study/Research Agreement with Ochsner Clinic Foundation

News | PET-CT

Positron Corporation Enters into Agreement with Ochsner Clinic Foundation for Clinical Study of its New “Affinity PET-CT 4D” Device

March 21, 2023 — Positron Corporation, a molecular imaging device company that offers PET imaging systems and clinical ...

March 21, 2023

RYZ101 positioned to be the first approved Actinium-225 radiopharmaceutical therapy for the industry

News | Radiopharmaceuticals and Tracers

RayzeBio Completes Phase 1b Enrollment in ACTION-1 Study, Evaluating RYZ101 (Actinium-225 DOTATATE) in Neuroendocrine Tumors

March 20, 2023 — RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against ...

March 20, 2023

UNSW Sydney researchers develop algorithm to significantly enhance images of hydrogen fuel cells, with potential future application in medical scanning

News | X-Ray

Deep Learning Tool Boosts X-ray Imaging Resolution and Hydrogen Fuel Cell Performance

March 20, 2023 — Researchers from UNSW Sydney have developed an algorithm which produces high-resolution modeled images ...

March 20, 2023

Novel manganese-based macrocyclic Magnetic Resonance Imaging (MRI) agent could offer an alternative to gadolinium-based agents

News | Contrast Media

GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

March 2, 2023 — GE HealthCare announced at the European Congress of Radiology (ECR) in Vienna, Austria, the completion ...

March 02, 2023

Study compared models of personal risk to current USPSTF screening guidelines

News | Lung Imaging

Lung Cancer Screening More Cost Effective When Using Risk Model-Based Strategies

February 10, 2023 — Risk model-based lung cancer screening strategies, which select individuals based on personal risk ...

February 10, 2023

Researcher conducts a breast cancer vaccine related experiment in a lab at Cleveland Clinic.

News | Clinical Trials

Cleveland Clinic Announces Next Step in Preventive Breast Cancer Vaccine Study

February 8, 2023 — Cleveland Clinic researchers have launched the next step in their novel study of a vaccine aimed at ...

February 08, 2023

The V Foundation for Cancer Research has announced a new grant program aimed at increasing female representation and female-led innovation in cancer research.

News | Radiation Oncology

New Grant Program by the V Foundation Established to Boost Female-led Cancer Research

February 2, 2023 — The V Foundation, a top cancer research charity, has announced the establishment of a new grant ...

February 02, 2023

PRISMA flow diagram shows identification, screening, and inclusion of studies

News | Magnetic Resonance Imaging (MRI)

MRI Surveillance for Postsurgical Musculoskeletal Soft-Tissue Sarcomas

February 1, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), MRI ...

February 01, 2023

Study finds that Black patients and patients living in certain regions experience greater delays.

News | Breast Imaging

Race and Geography Linked to Different Risks of Breast Cancer Treatment Delays

January 24, 2023 — For patients with cancer, lengthy delays in treatment can decrease their chances of survival. In an ...

January 24, 2023

Deciphex, a Dublin-based software company focused on developing digital pathology-based software and services for clinical and research pathology, has announced the rollout of its Automated Image Quality Control (QC) for digital research pathology.

News | Digital Pathology

Digital Pathology Software Firm Deciphex Builds Automated Image QC into Research Platform

January 19, 2023 — In an effort to speed up the research study process, Deciphex has announced the rollout of its ...

January 19, 2023

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines — such as doxorubicin, frequently used against breast cancer — kill cancer cells by damaging their DNA. However, these effective chemotherapies also cause toxic effects in the heart in about ten percent of patients that can eventually lead to heart failure, particularly in older patients with pre-existing cardiovascular disease. Current

News | Breast Imaging

Researchers ID Protein that may Protect the Heart During Certain Cancer Treatment Regimens

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including ...

December 29, 2022

News | Lung Imaging

Study Suggests AI can Predict Risk of Lung Cancer Returning Using CT Scans

December 26, 2022 — Artificial intelligence (AI) could help identify the risk of cancer returning in non-small cell lung ...

December 26, 2022

An imaging agent just approved by the FDA will allow surgeons to identify additional cancerous lesions, which otherwise would have been left behind, in up to 24% more patients during non-small cell lung cancer surgery. Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, is an inventor of the foundational intellectual property upon which the drug is based.

News | Lung Imaging

Imaging Agent Illuminates Lung Cancer Tumors

December 21, 2022 — Surgery, especially surgery to remove cancerous tumors, relies on a range of tools and techniques as ...

December 21, 2022

Researchers reveal new noninvasive MRI measures of the glymphatic system function that could be used to track Alzheimer disease progression

News | Magnetic Resonance Imaging (MRI)

Impaired Glymphatic System May be Linked with Progression of Alzheimer's Disease, Finds New Study

December 19, 2022 — The glymphatic system is the waste clearing pathway of the human brain. It is speculated that an ...

December 19, 2022

data showed that CytoSite’s Granzyme B (GzmB) PET imaging using [68Ga-NOTA]-hGZP (CSB-111) was feasible and safe in human subjects. These data come from a Phase I trial assessing the safety and feasibility of GzmB PET imaging in subjects with melanoma and non-small cell lung cancer (NSCLC) receiving KEYTRUDA (pembrolizumab).

News | Clinical Trials

CytoSite Bio Presents First-in-Human Data at Radiological Society of North American Annual Meeting

December 14, 2022 — CytoSite Bio, a company developing precision imaging products that determine patient response to ...

December 14, 2022

Prof. Dr. Franz Pfeiffer (back, left), Professor for Biomedical Physics, and his team have developed a prototype of a clinical CT scanner which combines dark-field and conventional X-ray technology (back right: Dr. Thomas Koehler, front left: Clemens Schmid, front right: Manuel Viermetz).

News | Coronavirus (COVID-19)

New X-ray Technology Can Improve COVID-19 Diagnosis

December 7, 2022 — A research team at the Technical University of Munich (TUM) has, for the first time, produced dark ...

December 07, 2022

Three-dimensional segmentation of ginger-root shaped necrotic lesions (yellow) and surrounding vasculature (red) within a sample of Mycobacterium tuberculosis-infected human lung tissue (transparent surface). Africa Health Research Institute

News | Coronavirus (COVID-19)

Tuberculosis and COVID-19 Lung lesions Revealed by High-Resolution Three-Dimensional Imaging

December 7, 2022 — Gross anatomy reveals three-dimensional shapes of pathology at a large scale. Histology, in contrast ...

December 07, 2022

A presentation during the Radiological Society of North America Scientific Session and Annual Meeting (RSNA 2022) featured IceCure Medical Ltd. and its minimally-invasive cryoablation technology, addressing Increasing interest among breast and interventional radiologists in performing breast tumor cryoablation.

News | RSNA

IceCure Medical Features Tumor Cryoablation Technology at RSNA 2022

December 9, 2022 — A poster presentation during the Radiological Society of North America Scientific Session and Annual ...

December 07, 2022

18F-rhPSMA-7.3 PET image showing multiple areas of uptake in the prostate gland in a man with newly diagnosed prostate cancer Photo courtesy of Blue Earth Diagnostics

News | Prostate Cancer

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer

December 2, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

December 02, 2022